JPMorgan China Growth & Income PLC
12 August 2026
12 August 2026
JPMORGAN CHINA GROWTH & INCOME PLC
(the "Company")
Statement re Reduction of Capital
Legal Entity Identifier: 549300S8M91P5FYONY25
The Company is pleased to announce that on 11 August 2026 the High Court of Justice (the "Court") confirmed the cancellation of the sums standing to the credit of the Company's share premium account and capital redemption reserve (the "Reduction of Capital").
The Court order confirming the Reduction of Capital, and a statement of capital approved by the Court in connection therewith, will be sent to the Registrar of Companies shortly. The Reduction of Capital will become effective upon the registration of the Court order and associated statement of capital by the Registrar of Companies.
The purpose of the Reduction of Capital is to create additional distributable reserves which will provide the Company with the flexibility to support, amongst other things, the buy-back of shares and the payment of dividends or other distributions in the future.
Shareholders do not need to take any further action in relation to the Reduction of Capital.
For further information, please contact:
Paul Winship
JPMorgan Funds Limited - Company Secretary
Telephone 0800 20 40 20 (or +44 1268 44 44 70)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.